OSOphira Salomon

Ophira Salomon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ophira Salomon has a total of 205 co-authors. Here are the top co-authors by number of shared publications:

  • David M. Steinberg

    Tel Aviv Univ, Fac Exact Sci, Dept Stat & Operat Res, Tel Aviv, Israel

    12 shared publications
  • Rima Dardik

    National Hemophilia Center and Thrombosis Unit, Sheba Medical Center, Tel-Hashomer, Israel

    7 shared publications
  • Ilia Tamarin

    The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Israel

    5 shared publications
  • Tami Livnat

    National Hemophilia Center and Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    5 shared publications
  • Yeroham Kleinbaum

    Diagnostic Imaging, Department of Radiology, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    5 shared publications
  • Nurit Rosenberg

    Amalia Biron Research Institute of Thrombosis and Haemostasis Sheba Medical Center Tel Hashomer and Sackler Faculty of Medicine Tel Aviv University Israel

    4 shared publications

Latest Publications

  • Open Access

    Combined Obstetric and Thrombotic Complications Are Associated with Features Suggestive of an Immune-Enriched Phenotype Among Women with Thrombotic Antiphospholipid Syndrome (APS)

    by Paula David, Gabrielle M. Santos, Or Hen, Juan Luis Ontiveros-Austria, Rotem Liran, Sergio Rodriguez-Rodriguez, Yonatan Shneor Patt, Erica Okazaki, Marina Colella, Gabriela G. Yamaguti-Hayakawa, et al.

    Background/Objectives: To determine whether obstetric antiphospholipid syndrome (oAPS) among women with primary thrombotic APS (tAPS) defines a distinct immunologic phenotype or influences thrombotic characteristics and recurrence risk. Methods: This predefined subgroup analysis was conducted within a multicenter retrospective cohort study of 663 patients with persistent antiphospholipid antibody (aPL) positivity and objectively confirmed thrombosis. The present analysis included 295 women with primary tAPS and a history of pregnancy. Participants were classified as oAPS or non-oAPS according to the revised Sydney criteria. Demographic, clinical, obstetric, immunologic, and hematologic features at baseline were compared. Univariable and multivariable logistic regression analyses were performed to identify predictors of oAPS and determinants of arterial versus venous thrombosis. Results: Of 295 women, 115 (39.0%) met oAPS criteria. ANA positivity (33.0% vs. 19.0%, p = 0.008), triple aPL positivity (46.0% vs. 29.1%, p = 0.003), and severe thrombocytopenia (22.8% vs. 13.3%, p = 0.035) were more frequent in oAPS. In multivariable analysis, ANA positivity remained independently associated with oAPS (adjusted OR 1.94, 95% CI 1.05–3.56; p = 0.033), whereas triple aPL positivity and thrombocytopenia did not remain independently significant after adjustment. Thrombotic phenotype and recurrence rates were similar between oAPS and non-oAPS groups. Obstetric history was not associated with arterial events; hypertension was the strongest predictor of arterial thrombosis (adjusted OR 2.61, p < 0.001). Conclusions: In primary tAPS, oAPS is associated with features suggestive of an immune-enriched phenotype, particularly ANA positivity, without evidence of a distinct thrombotic phenotype or increased recurrence risk. Integration of obstetric and immunologic features may help guide risk stratification and hypothesis generation for future studies.

  • Open Access

    Factor XI Deficiency in apoE/FXI Double-Knockout Mice Decreases Atherosclerosis by Lowering MSR1 mRNA Expression Within the Plaque

    by Reut Shnerb Ganor, Elvezia M. Paraboschi, Duga Stefano, Dror Harats, Rosanna Asselta, Ginette Schiby, Gil S. Leichner, Mika Anekstein Spigel, Ilia Tamarin, Michal Kandel Kfir, et al.

    Shnerb Ganor R, et al. J Lipid Atheroscler. 2025 Sep;14(3):372-383. https://doi.org/10.12997/jla.2025.14.3.372

  • Open Access

    Aortic Clamping Time Is Associated With Postoperative Thrombocytopenia Following Elective Open Abdominal Aortic Surgery

    by Victor Bilman, Jonathan Alk, Moshe Halak, Chen Speter, Ophira Salomon, Daniel Silverberg

    Objective: The objective of this study was to evaluate the incidence of thrombocytopenia following elective abdominal aortic surgery and identify the associated risk factors. Methods: From 2009 to 2020, all consecutive patients undergoing elective open infrarenal abdominal aortic repair for aneurysms (AAAs) or aortic occlusive disease (AOD) were included in a prospectively maintained dedicated database and subsequently analyzed retrospectively. The perioperative dataset included the duration of surgery, aortic clamping time, graft configurations, blood loss, and blood products administered during the procedure. Univariate and multivariable analyses were conducted to identify risk factors for postoperative thrombocytopenia and assess its clinical consequences. Results: A total of 100 patients (male n = 81, mean age of 68 ± 9.3 years) were included in the present study. The AAA group showed a higher prevalence of hypertension ( n = 58 [76%]) versus AOD ( n = 12 [50%]) with p = 0.014 and the use of vancomycin presurgery prophylaxis, n = 36 (47%) and n = 7 (29%), respectively, with p = 0.033. The AOD group presented a higher number of active smokers ( n = 19 [79%]) versus AAA group ( n = 30 [39%]) with p < 0.001. The overall mean operative aortic clamping time was 91.6 ± 35 min, with a significantly longer time in the AAA group (96.0 ± 36.1 min vs. 78.8 ± 28.5 min in the AOD group) with p = 0.046. The mean estimated blood loss was 1383 ± 834 mL, with a higher average of 1546 ± 878 mL in the AAA group versus 933 ± 472 mL in the AOD group with p = 0.002. A decrease in the platelet count was observed immediately after surgery, with a mean reduction from baseline of 40.5 % ± 16.3 % in the AAA, 41.9 ± 16.4 % compared to 35.9 % ± 15.4 % in the AOD group with p = 0.553, reaching its nadir on postoperative Days 2 and 3. No major bleeding events associated with thrombocytopenia during the postoperative period were recorded. In 54 patients (54%), the platelet count returned to baseline by postoperative Day 5 (POD 5). Five patients exhibited a sustained platelet count drop of > 50% from baseline on POD 5 and were tested for heparin‐induced thrombocytopenia, all of which returned negative results. On multivariable analysis, the patient age (OR 1.125; 95% CI: 1.024–1.236; p = 0.014) and clamping time (OR 1.034; 95% CI: 1.011–1.058; p = 0.004) were independently associated with a decrease in the platelet count. Conclusion: Postoperative thrombocytopenia is common following an elective abdominal aortic surgery, but it was demonstrated that it typically resolves on its own by POD 5 without significant clinical consequences. The study identified the patient age, and aortic clamping time as independent risk factors for the development of thrombocytopenia. However, further research involving larger cohorts is needed to confirm these findings and better understand the underlying mechanisms and potential implications.

  • Thrombotic Thrombocytopenic Purpura and Other Thrombotic Microangiopathic Hemolytic Anemias

    by Boris Shenkman, Yulia Einav, Ophira Salomon, Yehuda Shoenfeld, Rocio Morán Contla, Abihai Lucas Hernández

  • JAK2V617F Is a Risk Factor for TIA/Stroke in Young Patients

    by Tamar Shapira Cohen, Gabriel Chodick, David M. Steinberg, Ehud Grossman, Mordechai Shohat, Ophira Salomon

    The objective of this study was to assess the risk of arterial thrombosis in patients who harbor the JAK2V617F allele burden ≥1% detected during workup for myeloproliferative neoplasms (MPNs). We conducted a large cross-sectional analysis consisted of 5,220 patients who were tested for JAK2V617F and 1,047,258 people matched in age from health care insurance provider, taking into account age, sex, hypertension, diabetes, atrial fibrillation. Compared with noncarriers, mutation carriers were older, less likely to be current or past smokers and had lower body mass index. There was no significant difference between the groups regarding myocardial infarction and peripheral vascular disease. However, JAK2V617F ≥1% at age 34 to 54 years was associated with eightfold more likely to have transient ischemic attack (TIA)/stroke history unrelated to hypertension, diabetes, or atrial fibrillation. Association of JAK2V617F with TIA/stroke was also observed in the older age group, albeit a weaker association and not statistically significant. Prevalence of TIA/stroke was higher in patients with JAK2V617F negative, with odds ratio of 3.93 when compared with the general population after confounder adjustments. Further research is warranted to verify the relation between allele burden of JAK2V617F mutation and TIA/stroke and the role of JAK2V617F per se as a risk factor for arterial thrombosis in the absence of overt MPN. Also, consideration should be paid to the screened group with JAK2V617F negative due to the high incidence of TIA/stroke among them in comparison to the general population.


  • Open Access

    An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study

    by Yehudit Eden Friedman, David M. Steinberg, Michal Canetti, Ido Cohen, Shlomo Segev, Ophira Salomon

    Background: Life expectancy has greatly increased, generating an improvement in screening programs for disease prevention, lifesaving drugs and medical devices. The impact of lowering low-density lipoprotein cholesterol (LDL-C) in the very elderly is not well-established. Our aim was to explore the association of LDL-C, high density lipoprotein cholesterol (HDL-C) and lipid lowering drugs (LLDs) on cognitive decline, malignancies and overall survival. Methods: This was a retrospective cohort study. Our study comprised 1498 (72.7%) males and 561 (27.3%) females, aged ≥70 who had attended the Institute for Medical Screening (IMS), Sheba Medical Center, Israel at least twice during 2013–2019. Data were obtained from the computerized database of the IMS. A manual quality control to identify potential discrepancies was performed. Results: Overall, 6.3% of the subjects treated with LLDs (95/1421) versus 4.2% not treated (28/638), cognitively declined during the study years. No statistically significant effects of LDL-C, HDL-C and LLDs on cognitive decline were observed after correcting for age, prior stroke and other vascular risk factors. With regard to cancer, after adjusting for confounders and multiple inferences, no definite relationships were found. Conclusions: This analysis of an elderly, high socioeconomic status cohort suggests several relationships between the use of LLDs and health outcomes, some beneficial, especially, with regard to certain types of cancer, but with a higher risk of cognitive decline. Further studies are warranted to clarify the health effects of these medications in the elderly.


  • Eculizumab-Responsive Adult Onset Protein Losing Enteropathy, Caused by Germline CD55-Deficiency and Complicated by Aggressive Angiosarcoma

    by David Hagin, Dror Lahav, Tal Freund, Sivan Shamai, Eli Brazowski, Sigal Fishman, Alina Kurolap, Hagit Baris Feldman, Mordechai Shohat, Ophira Salomon


  • Open Access

    The effect of civil and military flights on coagulation, fibrinolysis and blood flow: insight from a rat model

    by Anna Levkovsky, Rima Dardik, Daniel Barazany, David M. Steinberg, Mark Dan Kirichenko, Sara Apter, Edna Peleg, Daniel Silverberg, Ehud Grossman, Ophira Salomon

    Background: Air travel thrombosis continues to be a controversial topic. Exposure to hypoxia and hypobaric conditions during air travel is assumed a risk factor. The aim of this study is to explore changes in parameters of coagulation, fibrinolysis and blood flow in a rat model of exposure to hypobaric conditions that imitate commercial and combat flights. Methods: Sixty Sprague-Dawley male rats, aged 10 weeks, were divided into 5 groups according to the type and duration of exposure to hypobaric conditions. The exposure conditions were 609 m and 7620 m for 2 and 12 h duration. Blood count, thrombin– antithrombin complex, D-dimer, interleukin-1 and interleukin-6 were analyzed. All rats went through flight angiography MRI at day 13-post exposure. Results: No effect of the various exposure conditions was observed on coagulation, fibrinolytic system, IL-1 or IL-6. MRI angiography showed blood flow reduction in lower limb to less than 30% in 50% of the rats. The reduction in blood flow was more pronounced in the left vessel than in the right vessel (p = 0.006, Wilcoxon signed rank test). The extent of occlusion differed across exposure groups in the right, but not the left vessel (p = 0.002, p = 0.150, respectively, Kruskal-Wallis test). However, these differences did not correlate with the exposure conditions. Conclusion: In the present rat model, no clear correlation between various hypobaric conditions and activation of coagulation was observed. The reduction in blood flow in the lower limb also occurred in the control group and was not related to the type of exposure.